U.S. markets closed
  • S&P 500

    3,870.29
    -31.53 (-0.81%)
     
  • Dow 30

    31,391.52
    -143.99 (-0.46%)
     
  • Nasdaq

    13,358.79
    -230.04 (-1.69%)
     
  • Russell 2000

    2,236.87
    -38.45 (-1.69%)
     
  • Crude Oil

    59.58
    -1.06 (-1.75%)
     
  • Gold

    1,731.70
    +8.70 (+0.50%)
     
  • Silver

    26.79
    +0.11 (+0.42%)
     
  • EUR/USD

    1.2092
    +0.0032 (+0.27%)
     
  • 10-Yr Bond

    1.4150
    -0.0310 (-2.14%)
     
  • GBP/USD

    1.3965
    +0.0045 (+0.32%)
     
  • USD/JPY

    106.7560
    +0.0260 (+0.02%)
     
  • BTC-USD

    47,597.11
    -885.32 (-1.83%)
     
  • CMC Crypto 200

    950.60
    -36.05 (-3.65%)
     
  • FTSE 100

    6,613.75
    +25.22 (+0.38%)
     
  • Nikkei 225

    29,408.17
    -255.33 (-0.86%)
     

CureVac Joins GlaxoSmithKline to Make Next-Gen Covid Shot

Feb.03 -- CureVac has joined forces with GlaxoSmithKline Plc to create a next-generation Covid mRNA shot that could help protect against multiple variants of the pathogen, and it’s extended a partnership with Bayer AG to allow the German pharma giant to produce CureVac’s vaccine. CureVac CEO Franz-Werner Haas spoke on "Bloomberg Markets."